Genetic and environmental risks for fatty liver–related liver cancer in Latino adults

Genetic and Environmental risk of NAFLD-related HCC In All Latinos: the GENIAL Study

NIH-funded research University of Miami School of Medicine · NIH-11175366

This project looks at how genes and life‑time exposures combine to change the chance that Latino adults with fatty liver will develop liver cancer.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniversity of Miami School of Medicine NIH-funded
Lab location1 site (Coral Gables, United States)
Project IDNIH-11175366 on NIH RePORTER

What this research studies

If you are a Latino adult with nonalcoholic fatty liver disease (NAFLD), researchers will use large, diverse health databases and genetic information to find patterns that raise the risk of liver cancer (HCC). They will combine genome‑wide scans, broad health‑record analyses, and polygenic risk scores to capture both inherited and environmental contributors across different Latino groups. The team will pool data from national programs like All of Us and regional resources such as UCLA ATLAS and work with liver clinics to make sure results reflect Latino diversity. The goal is to create more precise risk estimates that could guide how closely people are monitored.

Who could benefit from this research

Good fit: The most relevant people are Latino adults with a diagnosis of NAFLD (with or without cirrhosis) or Latino participants already enrolled in All of Us, UCLA ATLAS, or liver‑clinic networks.

Not a fit: People who are not Latino, children, or those with liver disease caused by alcohol, viruses, or other non‑NAFLD causes may not benefit directly from the findings.

Why it matters

Potential benefit: If successful, this work could help identify Latino patients at higher risk for NAFLD-related liver cancer so they can get earlier monitoring or preventive care.

How similar studies have performed: Previous genetic studies have identified variants (for example PNPLA3) linked to fatty liver and related outcomes, but few have included diverse Latino populations, so this approach builds on prior successes while addressing a gap.

Where this research is happening

Coral Gables, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.